z-logo
open-access-imgOpen Access
Diagnostic yield of medical thoracoscopy in cases of undiagnosed pleural effusion in Kobri El-Kobba Military Hospital
Author(s) -
Laila A. Helala,
Gehan Elassal,
Ayman A. Farghally,
Marwa M. Abd El Rady
Publication year - 2014
Publication title -
egyptian journal of chest diseases and tuberculosis/egyptian journal of chest diseases and tuberculosis
Language(s) - English
Resource type - Journals
eISSN - 2090-9950
pISSN - 0422-7638
DOI - 10.1016/j.ejcdt.2014.04.002
Subject(s) - medicine , thoracoscopy , malignancy , gold standard (test) , pleural effusion , empyema , surgery , malignant pleural effusion , tuberculosis , general surgery , radiology , pathology
BackgroundRecurrent and persistent pleural exudates are common in clinical practice, and in a large number of patients, thoracocentesis and blind pleural biopsy procedures do not provide a definitive diagnosis. In the Western world, the majority of these exudates are malignant. Thoracoscopy today remains the gold standard technique in providing diagnosis and management in these cases.ObjectivesDiagnostic yield of medical thoracoscopy was evaluated in cases of undiagnosed pleural effusion.Patients and methodsSemi flexible medical thoracoscopy was done for 40 patients in the period between March 2010 and October 2012 in Kobri El-Kobba Military chest Hospital through double points of entry.ResultsMedical thoracoscopy gave a definitive diagnosis in 38 out of 40 patients with diagnostic yield 95%. Malignancy was diagnosed in 28 patients (70%), one patient was diagnosed as empyema (2.5%), tuberculosis was found in 9 patients (22.5%), and it was non diagnostic in 2 patients (5%). The post-thoracoscopic complications in the studied group have occurred only in 4 patients (10%).ConclusionMedical thoracoscopy is a valuable tool in the diagnosis of undiagnosed exudative pleural effusion. It is a simple and safe method with high diagnostic yield and with low complication rates

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here